Piispanristi, Finland

Maarit Hillilä

This inventor holds 2 USPTO granted patents. Top assignee: Orion Corporation. Active years: 2001-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Maarit Hillilä. Retrieved from https://idiyas.com/inventor/maarit-hillilandauml

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2001-2002

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Maarit Hillilä

Introduction

Maarit Hillilä is a prominent inventor based in Piispanristi, Finland. She has made significant contributions to the field of pharmaceuticals, particularly in the development of imidazole derivatives. With a total of 2 patents to her name, her work has garnered attention in the scientific community.

Latest Patents

Among her latest patents are innovative compounds titled "Imidazole derivatives having affinity for α2 receptors" and "Imidazole derivatives of formula (I)." These patents reflect her expertise in creating compounds that interact with specific receptors, which can have important implications in medical treatments.

Career Highlights

Maarit Hillilä is currently associated with Orion Corporation, a leading pharmaceutical company in Finland. Her role at Orion has allowed her to focus on research and development, contributing to the advancement of new therapeutic options.

Collaborations

Throughout her career, Maarit has collaborated with notable colleagues, including Arto J Karjalainen and Paavo Huhtala. These partnerships have enhanced her research efforts and expanded the impact of her work in the pharmaceutical industry.

Conclusion

In summary, Maarit Hillilä is a talented inventor whose work in imidazole derivatives is paving the way for new advancements in pharmaceuticals. Her contributions are significant, and her collaborations further amplify her impact in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…